Global Direct-to-Consumer Laboratory Testing
Global Direct-to-Consumer Laboratory Testing

Direct-to-Consumer Laboratory Testing Comprehensive Study by Application (Adult, Children), Type (Blood, Urine, Saliva, Others), End-use (Hospitals, Clinics, Specialty labs,, Diagnostic centers.) Players and Region - Global Market Outlook to 2026

Direct-to-Consumer Laboratory Testing Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Nov 2021 Edition 214 Pages 211 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Direct-to-Consumer Laboratory Testing Market Scope
Direct-to-consumer (DTC) laboratory testing is known as direct access testing that enables patients to order tests directly from the laboratory without physical visiting to a healthcare practitioner. Direct-To-Consumer consists of advanced technology tests which can be used to track a current health condition, diagnose a previously undiagnosed medical issue, or provide information on personal health traits. DTC laboratory testing plays an important for customer engagement in their healthcare with accurate and accessible testing samples. Due to the increased hetic lifestyle which is associated and infectious diseases such as obesity, hypertension, diabetes, cancer, and STD has increased. Geographically, North America is the leading region for higher adoption for direct-to-customer laboratory testing due to an increase in heart disease and cancer which is triggering for higher adoption direct to customer laboratory testing. The demand for direct-to-customer laboratory testing is driving the growth of the market over the forecast period.

The Direct-to-Consumer Laboratory Testing market study is segmented, by Application (Adult and Children) and major geographies with country level break-up.

The market is expected to grow market in hospitals. It has wide application various clinical programs and seminars is driving the demand for the market. Several companies such as EverlyWell, Inc, Laboratory Corporation of America Holding, DirectLabs, LLC are operating in the market to provide customers with better offers with various features & unique offerings. The market is a partially fragmented market with the presence of several market players and local players. Which is triggering the market growth over the forecast perio

EverlyWell, Inc (United States), Laboratory Corporation of America Holding (United States), DirectLabs, LLC (United States), MyMedLab, Inc (United States), WellnessFX (United States), ANY LAB TEST NOW (United States), LetsGetChecked (Ireland), Color Health (United States), 23andMe, Inc (United States), Sonora Quest (United States), Ancestry.com LLC (United States) and Others are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Direct-to-Consumer Laboratory Testing market by Type, Application and Region.

On the basis of geography, the market of Direct-to-Consumer Laboratory Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
On July 2021 Genetic technologies had acquired DTC Genetic Test Provider for EasyDNA.The acquisition cost is USD 4M., and In June 2021 Eurofins has acquired a DNA diagnostics Centre to grow genetic testing Capabilities and significantly into the Consumer Testing Market
On November 2021, Cue Health has launched a Direct-To-Consumer virtual health platform kind to test available to people across the United States through Cue's new e-commerce site and app shop


Market Trend
  • Laboratory Information and Management Systems (LIMS) are currently the solution to data management in modern laboratories for data tracking

Market Drivers
  • It is easy to order
  • It is easily Access able from remote locations at any time and any location

Opportunities
  • Rising demand with advances in technology such machine learning for faster testing result

Restraints
  • It is easy to order
  • It is easily Access able from remote locations at any time and any location

Challenges
  • Negative testing may increase your stress and anxiety.


Key Target Audience
OEM (Original Equipment Manufacturing), Supplier, Regulatory Authorities, New Entrants/Investors, Strategic Business Planners, Governments and End-Use Industry

Frequently Asked Questions (FAQ):

1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Direct-to-Consumer Laboratory Testing Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Report Objectives / Segmentation Covered
By Application
  • Adult
  • Children
By Type
  • Blood
  • Urine
  • Saliva
  • Others

By End-use
  • Hospitals
  • Clinics
  • Specialty labs,
  • Diagnostic centers.

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. It is easy to order
      • 3.2.2. It is easily Access able from remote locations at any time and any location
    • 3.3. Market Challenges
      • 3.3.1. Negative testing may increase your stress and anxiety.
    • 3.4. Market Trends
      • 3.4.1. Laboratory Information and Management Systems (LIMS) are currently the solution to data management in modern laboratories for data tracking
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Direct-to-Consumer Laboratory Testing, by Application, Type, End-use and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Direct-to-Consumer Laboratory Testing (Value)
      • 5.2.1. Global Direct-to-Consumer Laboratory Testing by: Type (Value)
        • 5.2.1.1. Blood
        • 5.2.1.2. Urine
        • 5.2.1.3. Saliva
        • 5.2.1.4. Others
      • 5.2.2. Global Direct-to-Consumer Laboratory Testing by: Application (Value)
        • 5.2.2.1. Adult
        • 5.2.2.2. Children
      • 5.2.3. Global Direct-to-Consumer Laboratory Testing by: Type (Value)
        • 5.2.3.1. Blood
        • 5.2.3.2. Urine
        • 5.2.3.3. Saliva
        • 5.2.3.4. Others
      • 5.2.4. Global Direct-to-Consumer Laboratory Testing by: End-use (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Clinics
        • 5.2.4.3. Specialty labs,
        • 5.2.4.4. Diagnostic centers.
      • 5.2.5. Global Direct-to-Consumer Laboratory Testing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Direct-to-Consumer Laboratory Testing (Price)
  • 6. Direct-to-Consumer Laboratory Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. EverlyWell, Inc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Laboratory Corporation of America Holding (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. DirectLabs, LLC (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. MyMedLab, Inc (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. WellnessFX (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ANY LAB TEST NOW (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. LetsGetChecked (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Color Health (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. 23andMe, Inc (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sonora Quest (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Ancestry.com LLC (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Others
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Direct-to-Consumer Laboratory Testing Sale, by Application, Type, End-use and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Direct-to-Consumer Laboratory Testing (Value)
      • 7.2.1. Global Direct-to-Consumer Laboratory Testing by: Type (Value)
        • 7.2.1.1. Blood
        • 7.2.1.2. Urine
        • 7.2.1.3. Saliva
        • 7.2.1.4. Others
      • 7.2.2. Global Direct-to-Consumer Laboratory Testing by: Application (Value)
        • 7.2.2.1. Adult
        • 7.2.2.2. Children
      • 7.2.3. Global Direct-to-Consumer Laboratory Testing by: Type (Value)
        • 7.2.3.1. Blood
        • 7.2.3.2. Urine
        • 7.2.3.3. Saliva
        • 7.2.3.4. Others
      • 7.2.4. Global Direct-to-Consumer Laboratory Testing by: End-use (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Clinics
        • 7.2.4.3. Specialty labs,
        • 7.2.4.4. Diagnostic centers.
      • 7.2.5. Global Direct-to-Consumer Laboratory Testing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Direct-to-Consumer Laboratory Testing (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Direct-to-Consumer Laboratory Testing: by Type(USD Million)
  • Table 2. Direct-to-Consumer Laboratory Testing Blood , by Region USD Million (2015-2020)
  • Table 3. Direct-to-Consumer Laboratory Testing Urine , by Region USD Million (2015-2020)
  • Table 4. Direct-to-Consumer Laboratory Testing Saliva , by Region USD Million (2015-2020)
  • Table 5. Direct-to-Consumer Laboratory Testing Others , by Region USD Million (2015-2020)
  • Table 6. Direct-to-Consumer Laboratory Testing: by Application(USD Million)
  • Table 7. Direct-to-Consumer Laboratory Testing Adult , by Region USD Million (2015-2020)
  • Table 8. Direct-to-Consumer Laboratory Testing Children , by Region USD Million (2015-2020)
  • Table 9. Direct-to-Consumer Laboratory Testing: by Type(USD Million)
  • Table 10. Direct-to-Consumer Laboratory Testing Blood , by Region USD Million (2015-2020)
  • Table 11. Direct-to-Consumer Laboratory Testing Urine , by Region USD Million (2015-2020)
  • Table 12. Direct-to-Consumer Laboratory Testing Saliva , by Region USD Million (2015-2020)
  • Table 13. Direct-to-Consumer Laboratory Testing Others , by Region USD Million (2015-2020)
  • Table 14. Direct-to-Consumer Laboratory Testing: by End-use(USD Million)
  • Table 15. Direct-to-Consumer Laboratory Testing Hospitals , by Region USD Million (2015-2020)
  • Table 16. Direct-to-Consumer Laboratory Testing Clinics , by Region USD Million (2015-2020)
  • Table 17. Direct-to-Consumer Laboratory Testing Specialty labs, , by Region USD Million (2015-2020)
  • Table 18. Direct-to-Consumer Laboratory Testing Diagnostic centers. , by Region USD Million (2015-2020)
  • Table 19. South America Direct-to-Consumer Laboratory Testing, by Country USD Million (2015-2020)
  • Table 20. South America Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 21. South America Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 22. South America Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 23. Brazil Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 24. Brazil Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 25. Brazil Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 26. Argentina Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 27. Argentina Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 28. Argentina Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 29. Rest of South America Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 30. Rest of South America Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 32. Asia Pacific Direct-to-Consumer Laboratory Testing, by Country USD Million (2015-2020)
  • Table 33. Asia Pacific Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 34. Asia Pacific Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 35. Asia Pacific Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 36. China Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 37. China Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 38. China Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 39. Japan Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 40. Japan Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 41. Japan Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 42. India Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 43. India Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 44. India Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 45. South Korea Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 46. South Korea Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 47. South Korea Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 48. Taiwan Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 49. Taiwan Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 50. Taiwan Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 51. Australia Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 52. Australia Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 53. Australia Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 56. Rest of Asia-Pacific Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 57. Europe Direct-to-Consumer Laboratory Testing, by Country USD Million (2015-2020)
  • Table 58. Europe Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 59. Europe Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 60. Europe Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 61. Germany Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 62. Germany Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 63. Germany Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 64. France Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 65. France Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 66. France Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 67. Italy Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 68. Italy Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 69. Italy Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 70. United Kingdom Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 71. United Kingdom Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 72. United Kingdom Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 73. Netherlands Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 74. Netherlands Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 75. Netherlands Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 76. Rest of Europe Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 77. Rest of Europe Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 78. Rest of Europe Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 79. MEA Direct-to-Consumer Laboratory Testing, by Country USD Million (2015-2020)
  • Table 80. MEA Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 81. MEA Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 82. MEA Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 83. Middle East Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 84. Middle East Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 85. Middle East Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 86. Africa Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 87. Africa Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 88. Africa Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 89. North America Direct-to-Consumer Laboratory Testing, by Country USD Million (2015-2020)
  • Table 90. North America Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 91. North America Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 92. North America Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 93. United States Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 94. United States Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 95. United States Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 96. Canada Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 97. Canada Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 98. Canada Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 99. Mexico Direct-to-Consumer Laboratory Testing, by Application USD Million (2015-2020)
  • Table 100. Mexico Direct-to-Consumer Laboratory Testing, by Type USD Million (2015-2020)
  • Table 101. Mexico Direct-to-Consumer Laboratory Testing, by End-use USD Million (2015-2020)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Direct-to-Consumer Laboratory Testing: by Type(USD Million)
  • Table 115. Direct-to-Consumer Laboratory Testing Blood , by Region USD Million (2021-2026)
  • Table 116. Direct-to-Consumer Laboratory Testing Urine , by Region USD Million (2021-2026)
  • Table 117. Direct-to-Consumer Laboratory Testing Saliva , by Region USD Million (2021-2026)
  • Table 118. Direct-to-Consumer Laboratory Testing Others , by Region USD Million (2021-2026)
  • Table 119. Direct-to-Consumer Laboratory Testing: by Application(USD Million)
  • Table 120. Direct-to-Consumer Laboratory Testing Adult , by Region USD Million (2021-2026)
  • Table 121. Direct-to-Consumer Laboratory Testing Children , by Region USD Million (2021-2026)
  • Table 122. Direct-to-Consumer Laboratory Testing: by Type(USD Million)
  • Table 123. Direct-to-Consumer Laboratory Testing Blood , by Region USD Million (2021-2026)
  • Table 124. Direct-to-Consumer Laboratory Testing Urine , by Region USD Million (2021-2026)
  • Table 125. Direct-to-Consumer Laboratory Testing Saliva , by Region USD Million (2021-2026)
  • Table 126. Direct-to-Consumer Laboratory Testing Others , by Region USD Million (2021-2026)
  • Table 127. Direct-to-Consumer Laboratory Testing: by End-use(USD Million)
  • Table 128. Direct-to-Consumer Laboratory Testing Hospitals , by Region USD Million (2021-2026)
  • Table 129. Direct-to-Consumer Laboratory Testing Clinics , by Region USD Million (2021-2026)
  • Table 130. Direct-to-Consumer Laboratory Testing Specialty labs, , by Region USD Million (2021-2026)
  • Table 131. Direct-to-Consumer Laboratory Testing Diagnostic centers. , by Region USD Million (2021-2026)
  • Table 132. South America Direct-to-Consumer Laboratory Testing, by Country USD Million (2021-2026)
  • Table 133. South America Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 134. South America Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 135. South America Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 136. Brazil Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 137. Brazil Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 138. Brazil Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 139. Argentina Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 140. Argentina Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 141. Argentina Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 142. Rest of South America Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 143. Rest of South America Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 144. Rest of South America Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 145. Asia Pacific Direct-to-Consumer Laboratory Testing, by Country USD Million (2021-2026)
  • Table 146. Asia Pacific Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 147. Asia Pacific Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 148. Asia Pacific Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 149. China Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 150. China Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 151. China Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 152. Japan Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 153. Japan Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 154. Japan Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 155. India Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 156. India Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 157. India Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 158. South Korea Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 159. South Korea Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 160. South Korea Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 161. Taiwan Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 162. Taiwan Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 163. Taiwan Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 164. Australia Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 165. Australia Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 166. Australia Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 167. Rest of Asia-Pacific Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 168. Rest of Asia-Pacific Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 169. Rest of Asia-Pacific Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 170. Europe Direct-to-Consumer Laboratory Testing, by Country USD Million (2021-2026)
  • Table 171. Europe Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 172. Europe Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 173. Europe Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 174. Germany Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 175. Germany Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 176. Germany Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 177. France Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 178. France Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 179. France Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 180. Italy Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 181. Italy Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 182. Italy Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 183. United Kingdom Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 184. United Kingdom Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 185. United Kingdom Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 186. Netherlands Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 187. Netherlands Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 188. Netherlands Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 189. Rest of Europe Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 190. Rest of Europe Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 191. Rest of Europe Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 192. MEA Direct-to-Consumer Laboratory Testing, by Country USD Million (2021-2026)
  • Table 193. MEA Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 194. MEA Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 195. MEA Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 196. Middle East Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 197. Middle East Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 198. Middle East Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 199. Africa Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 200. Africa Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 201. Africa Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 202. North America Direct-to-Consumer Laboratory Testing, by Country USD Million (2021-2026)
  • Table 203. North America Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 204. North America Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 205. North America Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 206. United States Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 207. United States Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 208. United States Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 209. Canada Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 210. Canada Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 211. Canada Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 212. Mexico Direct-to-Consumer Laboratory Testing, by Application USD Million (2021-2026)
  • Table 213. Mexico Direct-to-Consumer Laboratory Testing, by Type USD Million (2021-2026)
  • Table 214. Mexico Direct-to-Consumer Laboratory Testing, by End-use USD Million (2021-2026)
  • Table 215. Research Programs/Design for This Report
  • Table 216. Key Data Information from Secondary Sources
  • Table 217. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Direct-to-Consumer Laboratory Testing: by Type USD Million (2015-2020)
  • Figure 5. Global Direct-to-Consumer Laboratory Testing: by Application USD Million (2015-2020)
  • Figure 6. Global Direct-to-Consumer Laboratory Testing: by Type USD Million (2015-2020)
  • Figure 7. Global Direct-to-Consumer Laboratory Testing: by End-use USD Million (2015-2020)
  • Figure 8. South America Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 9. Asia Pacific Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 10. Europe Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 11. MEA Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 12. North America Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 13. Global Direct-to-Consumer Laboratory Testing share by Players 2020 (%)
  • Figure 14. Global Direct-to-Consumer Laboratory Testing share by Players (Top 3) 2020(%)
  • Figure 15. Global Direct-to-Consumer Laboratory Testing share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. EverlyWell, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 18. EverlyWell, Inc (United States) Revenue: by Geography 2020
  • Figure 19. Laboratory Corporation of America Holding (United States) Revenue, Net Income and Gross profit
  • Figure 20. Laboratory Corporation of America Holding (United States) Revenue: by Geography 2020
  • Figure 21. DirectLabs, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 22. DirectLabs, LLC (United States) Revenue: by Geography 2020
  • Figure 23. MyMedLab, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 24. MyMedLab, Inc (United States) Revenue: by Geography 2020
  • Figure 25. WellnessFX (United States) Revenue, Net Income and Gross profit
  • Figure 26. WellnessFX (United States) Revenue: by Geography 2020
  • Figure 27. ANY LAB TEST NOW (United States) Revenue, Net Income and Gross profit
  • Figure 28. ANY LAB TEST NOW (United States) Revenue: by Geography 2020
  • Figure 29. LetsGetChecked (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. LetsGetChecked (Ireland) Revenue: by Geography 2020
  • Figure 31. Color Health (United States) Revenue, Net Income and Gross profit
  • Figure 32. Color Health (United States) Revenue: by Geography 2020
  • Figure 33. 23andMe, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 34. 23andMe, Inc (United States) Revenue: by Geography 2020
  • Figure 35. Sonora Quest (United States) Revenue, Net Income and Gross profit
  • Figure 36. Sonora Quest (United States) Revenue: by Geography 2020
  • Figure 37. Ancestry.com LLC (United States) Revenue, Net Income and Gross profit
  • Figure 38. Ancestry.com LLC (United States) Revenue: by Geography 2020
  • Figure 39. Others Revenue, Net Income and Gross profit
  • Figure 40. Others Revenue: by Geography 2020
  • Figure 41. Global Direct-to-Consumer Laboratory Testing: by Type USD Million (2021-2026)
  • Figure 42. Global Direct-to-Consumer Laboratory Testing: by Application USD Million (2021-2026)
  • Figure 43. Global Direct-to-Consumer Laboratory Testing: by Type USD Million (2021-2026)
  • Figure 44. Global Direct-to-Consumer Laboratory Testing: by End-use USD Million (2021-2026)
  • Figure 45. South America Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 46. Asia Pacific Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 47. Europe Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 48. MEA Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 49. North America Direct-to-Consumer Laboratory Testing Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • EverlyWell, Inc (United States)
  • Laboratory Corporation of America Holding (United States)
  • DirectLabs, LLC (United States)
  • MyMedLab, Inc (United States)
  • WellnessFX (United States)
  • ANY LAB TEST NOW (United States)
  • LetsGetChecked (Ireland)
  • Color Health (United States)
  • 23andMe, Inc (United States)
  • Sonora Quest (United States)
  • Ancestry.com LLC (United States)
  • Others
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation